morning traders 17 / 10, page-73

https://trademarketresearch.com/143...growing-number-of-applications-in-the-market/

Duchenne Muscular Dystrophy Therapeutics Market is expected to witness high demand on account of the growing number of applications in the market


Market Segment by Manufacturers, this report covers:

Bristol-Myers Squibb (market cap 94 billion)
FibroGen (U.S.) (market cap 4.5 billion)
Italfarmaco (Italy)
Marathon
NS Pharma (U.S.)
PTC Therapeutics (U.S.) (market cap 1.9 billion)
Pfizer (market cap 260 billion)
ReveraGen BioPharma (U.S.)
Santhera Pharmaceuticals (Switzerland)
Sarepta Therapeutics (U.S.) (market cap 9.1 billion)

What's the market cap of little old ANP?!